Clinical Trial Update: Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

View source ↗

Summary

This completed clinical trial assessed the prevalence of Alpha-1 Antitrypsin Deficiency among individuals with Chronic Obstructive Pulmonary Disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Alpha-1 Foundation | Conditions: Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease | Status: COMPLETED